These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7720589)

  • 1. Repression of Pax-2 by WT1 during normal kidney development.
    Ryan G; Steele-Perkins V; Morris JF; Rauscher FJ; Dressler GR
    Development; 1995 Mar; 121(3):867-75. PubMed ID: 7720589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pax-2, kidney development, and oncogenesis.
    Dressler GR
    Med Pediatr Oncol; 1996 Nov; 27(5):440-4. PubMed ID: 8827071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
    Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
    Eccles MR; Yun K; Reeve AE; Fidler AE
    Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
    Martinerie C; Chevalier G; Rauscher FJ; Perbal B
    Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation.
    Davies JA; Ladomery M; Hohenstein P; Michael L; Shafe A; Spraggon L; Hastie N
    Hum Mol Genet; 2004 Jan; 13(2):235-46. PubMed ID: 14645201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Pax-2 regulatory sequences that direct transgene expression in the Wolffian duct and its derivatives.
    Kuschert S; Rowitch DH; Haenig B; McMahon AP; Kispert A
    Dev Biol; 2001 Jan; 229(1):128-40. PubMed ID: 11133159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific regulation of the WT1 locus.
    Hewitt JA; Kessler PM; Campbell CE; Williams BR
    Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sp1 is a critical regulator of the Wilms' tumor-1 gene.
    Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP
    J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
    Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
    J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ expression of the early growth response gene-1 during murine nephrogenesis.
    Rackley RR; Kessler PM; Campbell C; Williams BR
    J Urol; 1995 Aug; 154(2 Pt 2):700-5. PubMed ID: 7609158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
    Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J
    Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
    McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
    Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
    Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
    Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus.
    Harrington MA; Konicek B; Song A; Xia XL; Fredericks WJ; Rauscher FJ
    J Biol Chem; 1993 Oct; 268(28):21271-5. PubMed ID: 8407965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor.
    Dressler GR; Douglass EC
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1179-83. PubMed ID: 1311084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development.
    Rothenpieler UW; Dressler GR
    Development; 1993 Nov; 119(3):711-20. PubMed ID: 8187639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1.
    Imgrund M; Gröne E; Gröne HJ; Kretzler M; Holzman L; Schlöndorff D; Rothenpieler UW
    Kidney Int; 1999 Oct; 56(4):1423-31. PubMed ID: 10504494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.